{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:56:23Z","timestamp":1792410983320,"version":"4.4.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.canlet.2021.10.019","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T11:20:58Z","timestamp":1634642458000},"page":"219-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer"],"prefix":"10.1016","volume":"524","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4639-328X","authenticated-orcid":false,"given":"Prabhakar Pitta","family":"Venkata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1390-9892","authenticated-orcid":false,"given":"Salvador","family":"Alejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0764-1893","authenticated-orcid":false,"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1716-3474","authenticated-orcid":false,"given":"Bridgitte E.","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilanna","family":"Loeffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday P.","family":"Pratap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7944-0759","authenticated-orcid":false,"given":"Sureshkumar Mulampurath","family":"Achuthan Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suryavathi","family":"Viswanadhapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9509-9511","authenticated-orcid":false,"given":"Srinath","family":"Palakurthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeshwar R.","family":"Tekmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2849-4076","authenticated-orcid":false,"given":"Ratna K.","family":"Vadlamudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Kost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9977-3932","authenticated-orcid":false,"given":"Gangadhara R.","family":"Sareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canlet.2021.10.019_bib1","first-page":"7","volume":"71","author":"Siegel","year":"2021","journal-title":"Ca - Cancer J. Clin."},{"issue":"849","key":"10.1016\/j.canlet.2021.10.019_bib2","article-title":"Recent advances in endometrial cancer: a review of key clinical trials from 2015 to 2019 [version 1; peer review: 2 approved]","volume":"8","author":"Charo","year":"2019","journal-title":"F1000Research"},{"key":"10.1016\/j.canlet.2021.10.019_bib3","series-title":"Endometrial Cancer Trends by Race and Histology in the USA: Projecting the Number of New Cases from 2015 to 2040","author":"Gaber","year":"2016"},{"key":"10.1016\/j.canlet.2021.10.019_bib4","series-title":"SEER Cancer Statistics Review, 1975\u20132012","author":"Howlader","year":"2015"},{"issue":"3","key":"10.1016\/j.canlet.2021.10.019_bib5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ygyno.2020.12.024","article-title":"Endometrial cancer: a society of gynecologic oncology evidence-based review and recommendations, part II","volume":"160","author":"Hamilton","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2021.10.019_bib6","series-title":"Principles and Practice of Gynecologic Oncology","first-page":"545","author":"Chi","year":"2017"},{"issue":"13","key":"10.1016\/j.canlet.2021.10.019_bib7","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1158\/1078-0432.CCR-12-3815","article-title":"PI3K pathway dependencies in endometrioid endometrial cancer cell lines","volume":"19","author":"Weigelt","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"7447","key":"10.1016\/j.canlet.2021.10.019_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"issue":"10023","key":"10.1016\/j.canlet.2021.10.019_bib9","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.canlet.2021.10.019_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ygyno.2015.09.083","article-title":"Emerging strategies for targeting PI3K in gynecologic cancer","volume":"140","author":"Bregar","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2021.10.019_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/jjco\/hyy159","article-title":"Molecular-targeted therapies and precision medicine for endometrial cancer","volume":"49","author":"Mitamura","year":"2018","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2021.10.019_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrc3037","article-title":"PTEN loss in the continuum of common cancers, rare syndromes and mouse models","volume":"11","author":"Hollander","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2021.10.019_bib13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ceb.2008.03.004","article-title":"Mechanisms involved in the regulation of histone lysine demethylases","volume":"20","author":"Lan","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/j.canlet.2021.10.019_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13072-018-0203-3","article-title":"KDM1A microenvironment, its oncogenic potential, and therapeutic significance","volume":"11","author":"Ismail","year":"2018","journal-title":"Epigenet. Chromatin"},{"issue":"8","key":"10.1016\/j.canlet.2021.10.019_bib15","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2217\/epi-2016-0009","article-title":"LSD1: biologic roles and therapeutic targeting","volume":"8","author":"Maiques-Diaz","year":"2016","journal-title":"Epigenomics"},{"issue":"8","key":"10.1016\/j.canlet.2021.10.019_bib16","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2217\/epi-2017-0022","article-title":"A comprehensive review of lysine-specific demethylase 1 and its roles in cancer","volume":"9","author":"Hosseini","year":"2017","journal-title":"Epigenomics"},{"issue":"1","key":"10.1016\/j.canlet.2021.10.019_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.18632\/oncotarget.725","article-title":"KDM1 is a novel therapeutic target for the treatment of gliomas","volume":"4","author":"Sareddy","year":"2013","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.canlet.2021.10.019_bib18","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/IGC.0000000000000500","article-title":"Overexpression of lysine-specific demethylase 1 is associated with tumor progression and unfavorable prognosis in Chinese patients with endometrioid endometrial adenocarcinoma","volume":"25","author":"Liu","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.canlet.2021.10.019_bib19","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1186\/1471-2407-14-752","article-title":"Reversible inhibition of lysine specific demethylase 1 is a novel anti-tumor strategy for poorly differentiated endometrial carcinoma","volume":"14","author":"Theisen","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2021.10.019_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fonc.2018.00255","article-title":"Lysine-specific demethylase 1A as a promising target in acute myeloid leukemia","volume":"8","author":"Magliulo","year":"2018","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.canlet.2021.10.019_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ccell.2015.06.002","article-title":"A DNA hypomethylation signature predicts antitumor activity of LSD1 inhibitors in SCLC","volume":"28","author":"Mohammad","year":"2015","journal-title":"Cancer Cell"},{"issue":"33","key":"10.1016\/j.canlet.2021.10.019_bib22","doi-asserted-by":"crossref","first-page":"8620","DOI":"10.1002\/anie.201303999","article-title":"Lysine-specific demethylase 1-selective inactivators: protein-targeted drug delivery mechanism","volume":"52","author":"Ogasawara","year":"2013","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.canlet.2021.10.019_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/srep24185","article-title":"Selective estrogen receptor \u03b2 agonist LY500307 as a novel therapeutic agent for glioblastoma","volume":"6","author":"Sareddy","year":"2016","journal-title":"Sci. Rep."},{"issue":"17","key":"10.1016\/j.canlet.2021.10.019_bib24","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/onc.2016.395","article-title":"Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway","volume":"36","author":"Sareddy","year":"2017","journal-title":"Oncogene"},{"issue":"W1","key":"10.1016\/j.canlet.2021.10.019_bib25","doi-asserted-by":"crossref","first-page":"W3","DOI":"10.1093\/nar\/gkw343","article-title":"The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update","volume":"44","author":"Afgan","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"15","key":"10.1016\/j.canlet.2021.10.019_bib26","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.canlet.2021.10.019_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.canlet.2021.10.019_bib28","doi-asserted-by":"crossref","first-page":"W187","DOI":"10.1093\/nar\/gku365","article-title":"deepTools: a flexible platform for exploring deep-sequencing data","volume":"42","author":"Ram\u00edrez","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2021.10.019_bib29","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26857","article-title":"Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers","volume":"6","author":"Raj","year":"2017","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.canlet.2021.10.019_bib30","first-page":"210","article-title":"Comparison of HSCORE assessment of endometrial beta3 integrin subunit expression with digital HSCORE using computerized image analysis (ImageJ)","volume":"35","author":"Fuhrich","year":"2013","journal-title":"Anal Quant Cytopathol Histpathol"},{"issue":"8","key":"10.1016\/j.canlet.2021.10.019_bib31","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2217\/epi-2016-0009","article-title":"LSD1: biologic roles and therapeutic targeting","volume":"8","author":"Maiques-Diaz","year":"2016","journal-title":"Epigenomics"},{"issue":"3","key":"10.1016\/j.canlet.2021.10.019_bib32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ccell.2018.02.002","article-title":"ORY-1001, a potent and selective covalent KDM1A inhibitor, for the treatment of acute leukemia","volume":"33","author":"Maes","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.canlet.2021.10.019_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-019-0811-9","article-title":"LSD1\/KDM1A inhibitors in clinical trials: advances and prospects","volume":"12","author":"Fang","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2021.10.019_bib34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-pathol-020117-043609","article-title":"Molecular genetics of endometrial carcinoma","volume":"14","author":"Bell","year":"2019","journal-title":"Annu. Rev. Pathol."},{"issue":"2","key":"10.1016\/j.canlet.2021.10.019_bib35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1158\/2159-8290.CD-11-0039","article-title":"High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability","volume":"1","author":"Cheung","year":"2011","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.canlet.2021.10.019_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/path.4056","article-title":"Use of mutation profiles to refine the classification of endometrial carcinomas","volume":"228","author":"McConechy","year":"2012","journal-title":"J. Pathol."},{"issue":"6","key":"10.1016\/j.canlet.2021.10.019_bib37","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1158\/1078-0432.CCR-10-0540","article-title":"A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas","volume":"17","author":"Rudd","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.canlet.2021.10.019_bib38","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1158\/1078-0432.CCR-07-0321","article-title":"Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma","volume":"14","author":"Lu","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2021.10.019_bib39","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/1541-7786.MCR-19-0748","article-title":"Lysine-specific demethylase 1 mediates AKT activity and promotes epithelial-to-mesenchymal transition in PIK3CA-mutant colorectal cancer","volume":"18","author":"Miller","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2021.10.019_bib40","article-title":"LSD1 activates PI3K\/AKT signaling through regulating p85 expression in prostate cancer cells","volume":"9","author":"Wang","year":"2019","journal-title":"Frontiers in oncology"},{"issue":"6","key":"10.1016\/j.canlet.2021.10.019_bib41","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.canlet.2021.10.019_bib42","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1158\/1078-0432.CCR-12-3815","article-title":"PI3K pathway dependencies in endometrioid endometrial cancer cell lines","volume":"19","author":"Weigelt","year":"2013","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"issue":"7447","key":"10.1016\/j.canlet.2021.10.019_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research","year":"2013","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.canlet.2021.10.019_bib44","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1002\/cncr.25515","article-title":"A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma","volume":"116","author":"Slomovitz","year":"2010","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2021.10.019_bib45","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ygyno.2014.01.015","article-title":"Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study","volume":"132","author":"Fleming","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"24","key":"10.1016\/j.canlet.2021.10.019_bib46","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1200\/JCO.2010.34.1578","article-title":"Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group","volume":"29","author":"Oza","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.canlet.2021.10.019_bib47","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1634\/theoncologist.2016-0062","article-title":"Chemotherapy for endometrial cancer in adjuvant and advanced disease settings","volume":"21","author":"Bestvina","year":"2016","journal-title":"Oncol."},{"issue":"3","key":"10.1016\/j.canlet.2021.10.019_bib48","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","article-title":"mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt","volume":"66","author":"O'Reilly","year":"2006","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.canlet.2021.10.019_bib49","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1158\/0008-5472.CAN-05-0917","article-title":"Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition","volume":"65","author":"Sun","year":"2005","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.canlet.2021.10.019_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082348","article-title":"Modeling endometrial cancer: past, present, and future","volume":"19","author":"Van Nyen","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.canlet.2021.10.019_bib51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/153303461000900207","article-title":"Genomic characterization of gene copy-number aberrations in endometrial carcinoma cell lines derived from endometrioid-type endometrial adenocarcinoma","volume":"9","author":"Wang","year":"2010","journal-title":"Technol. Cancer Res. Treat."},{"issue":"5","key":"10.1016\/j.canlet.2021.10.019_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037431","article-title":"Genotype-dependent efficacy of a dual PI3K\/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas","volume":"7","author":"Shoji","year":"2012","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.canlet.2021.10.019_bib53","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/sj.onc.1209990","article-title":"Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism","volume":"26","author":"Wan","year":"2007","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.canlet.2021.10.019_bib54","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","article-title":"Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2","volume":"55","author":"Copps","year":"2012","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.canlet.2021.10.019_bib55","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-05-0068","article-title":"Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor\/insulin receptor substrate-1\/phosphatidylinositol 3-kinase cascade","volume":"4","author":"Shi","year":"2005","journal-title":"Mol. Cancer Therapeut."},{"issue":"4","key":"10.1016\/j.canlet.2021.10.019_bib56","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"mTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2021.10.019_bib57","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13578-020-00416-0","article-title":"Roles of the PI3K\/AKT\/mTOR signalling pathways in neurodegenerative diseases and tumours","volume":"10","author":"Xu","year":"2020","journal-title":"Cell Biosci."},{"issue":"6","key":"10.1016\/j.canlet.2021.10.019_bib58","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/ncb995","article-title":"Rheb is an essential regulator of S6K in controlling cell growth in Drosophila","volume":"5","author":"Stocker","year":"2003","journal-title":"Nat. Cell Biol."},{"issue":"45","key":"10.1016\/j.canlet.2021.10.019_bib59","doi-asserted-by":"crossref","first-page":"11818","DOI":"10.1073\/pnas.1716173114","article-title":"Twenty-five years of mTOR: uncovering the link from nutrients to growth","volume":"114","author":"Sabatini","year":"2017","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"2","key":"10.1016\/j.canlet.2021.10.019_bib60","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1091\/mbc.e05-05-0469","article-title":"The inositol polyphosphate 5-phosphatase, PIPP, Is a novel regulator of phosphoinositide 3-kinase-dependent neurite elongation","volume":"17","author":"Ooms","year":"2006","journal-title":"Mol. Biol. Cell"},{"issue":"2","key":"10.1016\/j.canlet.2021.10.019_bib61","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1194\/jlr.R059154","article-title":"Phosphatidylinositolphosphate phosphatase activities and cancer","volume":"57","author":"Rudge","year":"2016","journal-title":"J. Lipid Res."},{"issue":"51","key":"10.1016\/j.canlet.2021.10.019_bib62","doi-asserted-by":"crossref","first-page":"36790","DOI":"10.1074\/jbc.274.51.36790","article-title":"Novel inositol polyphosphate 5-phosphatase localizes at membrane ruffles","volume":"274","author":"Mochizuki","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.canlet.2021.10.019_bib63","doi-asserted-by":"crossref","first-page":"10870","DOI":"10.1074\/jbc.275.15.10870","article-title":"Identification and characterization of a novel inositol polyphosphate 5-phosphatase","volume":"275","author":"Ijuin","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.canlet.2021.10.019_bib64","doi-asserted-by":"crossref","first-page":"11376","DOI":"10.1074\/jbc.M209991200","volume":"278","author":"Gurung","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2021.10.019_bib65","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/ncomms2489","article-title":"PI(4,5)P2 5-phosphatase A regulates PI3K\/Akt signalling and has a tumour suppressive role in human melanoma","volume":"4","author":"Ye","year":"2013","journal-title":"Nat. Commun."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383521005279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383521005279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:02:06Z","timestamp":1759593726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383521005279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":65,"alternative-id":["S0304383521005279"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2021.10.019","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2021.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}